Clinical Trial Update: Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Sofosbuvir with Pegylated Interferon and Ribavirin in chronic hepatitis C patients across genotypes 1, 4, 5, and 6 completed; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2014-05-26